FIELMANN AG (ADR/1/5)O.N. Total Liabilities
FIELMANN AG (ADR/1/5)O.N. total liabilities. Based on the latest financial reports, FIELMANN AG (ADR/1/5)O.N. (FIE1) has total liabilities worth €1.42 Billion EUR (≈ $1.66 Billion USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check FIELMANN AG (ADR/1/5)O.N. (FIE1) asset resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of FIELMANN AG (ADR/1/5)O.N. (2021–2024)
Total liabilities of FIELMANN AG (ADR/1/5)O.N. from 2021 to 2024. This chart illustrates how FIELMANN AG (ADR/1/5)O.N.'s total liabilities have evolved over time, based on quarterly financial data.
FIELMANN AG (ADR/1/5)O.N. Competitors by Total Liabilities
The table below lists competitors of FIELMANN AG (ADR/1/5)O.N. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Emcure Pharmaceuticals Ltd
NSE:EMCURE
|
India | Rs46.36 Billion |
|
Auras Technology Co Ltd
TWO:3324
|
Taiwan | NT$14.63 Billion |
|
KINGDEE INT. UNS.ADR/100
F:KDID
|
Germany | €6.38 Billion |
|
Alm. Brand
CO:ALMB
|
Denmark | Dkr20.05 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥8.08 Billion |
|
Dorman Products Inc
NASDAQ:DORM
|
USA | $968.43 Million |
|
Tango Therapeutics Inc
NASDAQ:TNGX
|
USA | $49.35 Million |
|
Predictive Discovery Ltd
AU:PDI
|
Australia | AU$6.91 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down FIELMANN AG (ADR/1/5)O.N.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see FIE1 total assets.
Liquidity & Leverage Metrics
FIELMANN AG (ADR/1/5)O.N. Total Liabilities Ratios Explained
FIELMANN AG (ADR/1/5)O.N. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.15 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.48 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.59 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how FIELMANN AG (ADR/1/5)O.N.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for FIELMANN AG (ADR/1/5)O.N. (2021–2024)
The table below shows the annual total liabilities of FIELMANN AG (ADR/1/5)O.N. from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €1.46 Billion ≈ $1.70 Billion |
+24.58% |
| 2023-12-31 | €1.17 Billion ≈ $1.37 Billion |
+27.92% |
| 2022-12-31 | €913.48 Million ≈ $1.07 Billion |
+5.84% |
| 2021-12-31 | €863.09 Million ≈ $1.01 Billion |
-- |
About FIELMANN AG (ADR/1/5)O.N.
Fielmann Group AG engages in vision care and audiology business in Germany, Switzerland, Austria, Spain, North America, and internationally. The company manufactures and sells visual aids mainly glasses, eyewear frames and lenses, sunglasses, contact lenses, accessories, hearing systems and its accessories, as well as personal protective equipment. It offers its products under the fielmann, Optik… Read more